• Rinaldo Bellomo, Paul M Palevsky, Sean M Bagshaw, Noel Gibney, Finlay A McAlister, Patrick M Honore, Olivier Joannes-Boyau, John Prowle, Michael Haase, Dinna N Cruz, and Claudio Ronco.
• Department of Intensive Care, Austin Hospital, Melbourne, Vic., Australia, USA. rinaldo.bellomo@med.monash.edu.au
• Contrib Nephrol. 2010 Jan 1; 165: 299-309.

AbstractSeveral large observational studies or randomized controlled trials in the field of critical care nephrology have been completed and reported, or recently completed or have recently begun recruitment. These studies provide important information to guide our appreciation of current practice and consider new potentially effective intervention for the prevention or attenuation of acute kidney injury or suggest new avenues for the use of renal replacement therapy (RRT) in the treatment of sepsis. In particular, two studies, the ATN study and the RENAL study (both multicenter randomized controlled trials of > 1,000 patients) provide, for the first time, level I evidence to guide the practice of RRT in critically ill patients and to better define the optimal intensity of such RRT in this setting. Clinicians practicing in the field of critical care nephrology need to be aware of these trials, their details, their findings or design or current recruitment rate and likely time of completion to continue to offer their patients the highest level of evidence-based medical care.2010 S. Karger AG, Basel.

38 keywords...

hide…